Utah Medical Marijuana Sales Reach $16.9 Million in April, Patient Count Tops 113,000
- Utah’s medical marijuana program saw growth in April with sales reaching nearly $17 million and active patients increasing to 113,202, up by 1,109 from March.
- The majority of patients (26.09%) are aged 31 to 40, with persistent pain being the dominant qualifying condition for nearly 98,684 patients.
- Cartridges and vape pens were the top-selling products in April, generating over $8.2 million in sales, followed by flower and infused edibles.
- Production remained strong with nearly 10,000 plants harvested and over 8.7 million grams of wet cannabis biomass produced, supporting sustained patient demand and increased monthly sales.
Utah’s medical marijuana market continued to grow in April, with sales reaching nearly $17 million and the number of active patients climbing above 113,000, according to the state’s latest monthly report.
The report, released, shows Utah had 113,202 patients with active medical cannabis cards as of the end of April. That’s up from 112,093 at the end of March, an increase of 1,109 patients in one month.
The program also includes 1,016 registered recommending medical providers, 916 processor and cultivator agents, 955 pharmacy agents, 443 courier agents and 95 pharmacy medical providers.
Patient demographics remained largely unchanged from March. Those ages 31 to 40 make up the largest share of patients at 26.09%, followed by those 41 to 50 at 22.34% and those 21 to 30 at 22%. Patients ages 51 to 65 account for 18.42%, while those 65 and older make up 11.07%.
Persistent pain continues to account for the overwhelming majority of qualifying conditions, with 98,684 patients listing it. PTSD was next at 5,613 patients, followed by nausea at 2,433, cancer at 2,091, autism at 770, MS at 724, epilepsy at 721 and Crohn’s disease at 573.
Sales also rose in April. Medical marijuana purchases totaled $16,911,700 for the month, up from $16,259,200 in March. When added to the nearly $50 million sold during the first three months of the year, Utah’s 2026 medical marijuana sales now total roughly $67 million.
Cartridges and vape pens remained the top-selling category, generating $8,208,000 in April sales. Flower followed at $5,454,500, while infused edibles brought in $2,996,900. Infused non-edible products accounted for $120,400, with non-medicated items such as pens, vaporizers, batteries and other devices adding $131,900.
Patient activity remained strong, with 64,997 patients making at least one purchase over the past 30 days. Over the past 90 days, 87,078 patients made at least one purchase, while 42,830 made four or more purchases.
On the production side, licensed medical marijuana pharmacies received 175,343 cartridges and pens from processors in April, along with 110,759 units of flower and 101,589 infused edible products.
Cultivators harvested over 9,885 medical marijuana plants in April across 210 planting batches, producing more than 8.7 million grams of wet cannabis biomass.
The April data shows continued growth across Utah’s medical marijuana program, with rising enrollment, higher monthly sales and sustained demand across the state’s leading product categories.